Previous 10 | Next 10 |
Nyxoah to Release Third Quarter 2023 Financial Results on November 8, 2023 Mont-Saint-Guibert, Belgium – October 26, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology...
2023-09-29 05:48:50 ET More on Nyxoah Seeking Alpha’s Quant Rating on Nyxoah Historical earnings data for Nyxoah Financial information for Nyxoah For further details see: Nyxoah partners with ResMed in Germany
Nyxoah Announces Partnership with ResMed in Germany C reates a continuum of care in the German obstructive sleep apnea market Mont-Saint-Guibert, Belgium – September 2 8 , 202 3 , 10 : 3 0 ...
Nyxoah to Participate in the Cantor Fit z gerald Global Healthcare Conference Mont-Saint-Guibert, Belgium – September 1 2 , 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Com...
Nyxoah to Participate in Upcoming Investor Conferences Mont-Saint-Guibert, Belgium – September 5 , 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology compa...
2023-08-11 10:10:04 ET Nyxoah S.A. (NYXH) Q2 2023 Earnings Conference Call August 08, 2023 04:30 PM ET Company Participants Mikaela Kirkwood - Corporate Communications & Investor Relations Manager Olivier Taelman - Chief Executive Officer Loic Moreau - Chief ...
REGULATED INFORMATION Nyxoah Reports Second Q uarter and First Half 2 02 3 Financial and Operating Results Mont-Saint-Guibert, Belgium – August 8 , 2023 10 : 0 5 pm CET / 4 : 0 5...
Nyxoah to Participate in the 43rd Canaccord Genuity Growth Conference Mont-Saint-Guibert, Belgium – July 27 , 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medic...
2023-05-16 20:34:06 ET Nyxoah S.A. (NYXH) Q1 2023 Earnings Conference Call May 16, 2023 16:30 ET Corporate Participants Mikaela Kirkwood - Corporate Communications and Investor Relations Manager Olivier Taelman - Chief Executive Officer Loic Moreau - Chief Financ...
2023-05-16 16:20:13 ET Nyxoah press release ( NASDAQ: NYXH ): Q1 GAAP EPS of -€0.46 misses by €0.08 . Revenue of €0.44M (-33.3% Y/Y) misses by €0.88M . Total operating loss for the first quarter 2023 was €11.4 million v...
News, Short Squeeze, Breakout and More Instantly...
Nyxoah Appoints Scott Holstine as Chief Commercial Officer Mont-Saint-Guibert, Belgium – July 15, 2024, 8:00am CET / 2:00am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the ...
REGULATED INFORMATION INSIDE INFORMATION Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank Mont-Saint-Guibert, Belgium – July 3, 2024, 12:30pm CET / 6:30am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (&...
Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA Mont-Saint-Guibert (Belgium), July 1, 2024 , 8:00am CET / 2:00am ET – (“Nyxoah” or the “Company”), a medical technology company focused on the develop...